HemaSphere (Jun 2022)
P519: TRANSFUSION INDEPENDENCE AMONG NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA PATIENTS RECEIVING VENETOCLAX-BASED COMBINATIONS VS OTHER THERAPIES: RESULTS FROM THE AML REAL WORLD EVIDENCE (ARC) INITIATIVE
- O. Wolach,
- J. S. Garcia,
- P. Vachhani,
- J. Zeidner,
- C. Lai,
- Y. Moshe,
- M. Xavier,
- S. Lee,
- T. Zuckerman,
- D. A. Pollyea,
- S. Abedin,
- E. C. Chen,
- S. Bathini,
- W. Edwards,
- C. N. Bui,
- W. W.-H. Cheng,
- A. Svensson,
- A. Guérin,
- J. Maitland,
- E. Ma,
- M. Montez,
- M. Grunspan,
- A. D. Goldberg
Affiliations
- O. Wolach
- 1 Rabin Medical Center, Petah Tikya, Israel
- J. S. Garcia
- 2 Dana-Farber Cancer Institute, Boston
- P. Vachhani
- 3 O’Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham
- J. Zeidner
- 4 University of North Carolina, Lineberger Comprehensive Cancer Center, Chapel Hill
- C. Lai
- 5 University of Pennsylvania Perelman Center for Advanced Medicine, Philadelphia, United States of America
- Y. Moshe
- 6 Tel Aviv (Sourasky) Medical Center, Tel Aviv, Israel
- M. Xavier
- 7 Scripps-MD Anderson, San Diego
- S. Lee
- 8 Janssen Research and Development, Springhouse, United States of America
- T. Zuckerman
- 9 Rambam Health Care Campus, Haifa, Israel
- D. A. Pollyea
- 10 University of Colorado School of Medicine, Aurora
- S. Abedin
- 11 Medical College of Wisconsin, Milwaukee
- E. C. Chen
- 2 Dana-Farber Cancer Institute, Boston
- S. Bathini
- 3 O’Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham
- W. Edwards
- 7 Scripps-MD Anderson, San Diego
- C. N. Bui
- 12 AbbVie Inc, North Chicago, United States of America
- W. W.-H. Cheng
- 12 AbbVie Inc, North Chicago, United States of America
- A. Svensson
- 12 AbbVie Inc, North Chicago, United States of America
- A. Guérin
- 13 Analysis Group Inc, Montreal, Canada
- J. Maitland
- 13 Analysis Group Inc, Montreal, Canada
- E. Ma
- 14 Genentech, South San Francisco, United States of America
- M. Montez
- 14 Genentech, South San Francisco, United States of America
- M. Grunspan
- 15 AbbVie Inc, Hod-Hasharon, Israel
- A. D. Goldberg
- 16 Memorial Sloan Kettering Cancer Center, New York, United States of America
- DOI
- https://doi.org/10.1097/01.HS9.0000844964.23639.25
- Journal volume & issue
-
Vol. 6
pp. 418 – 419
Abstract
No abstracts available.